Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Retatrutide for Sale > High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size
High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size buy - large image1
High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size buy - image1
High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size buy - image2
High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size buy - image3
High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size buy - image4
High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size buy - image5
High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size buy - image6

High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size

6842 Inquiries

Unit Price:

$60-65/G EXW

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Packaging:

5mg 10mg 20mg 30mg 50mg /vial,10vials/box

Price valid (until):

2026-12-01

Company Type:
Trader
Location:
China
Qualification:
Main Products:

PEPTIDES

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Name: Kitty

    WhatsApp:+86 135 2654 2669



    Are there discounts available?
    Answer: Yes, the larger the purchase quantity, the greater the discount.

    All employees of the company are committed to the continuous pursuit of superior quality and an impeccable brand image. Upholding a spirit of integrity, diligence, truth-seeking, and progress—and guided by the business philosophy that "quality is life and service is the soul"—they provide first-class products and services to meet market demands and stand ready to face market challenges at all times.


    Product  Description:


    Retatrutide (LY‑3437943, CAS No.2381089‑83‑2), also known as triple‑receptor agonist peptide, targets GLP‑1R, GIPR and GCGR receptors simultaneously. This product is lyophilized peptide powder with purity ≥99% by HPLC. It is strictly limited to scientific laboratory research, pre‑clinical pharmacological study and new drug intermediate development. Application research fields: energy metabolism research, obesity related mechanism research, T2DM study, visceral fat research, fatty liver (MASLD/MASH) and metabolic syndrome laboratory testing. We are the direct manufacturer. Stable stock, various specifications, sample order acceptable. All products are inspected before shipment, complete documents including COA, HPLC report and SDS can be supplied.



    Items Specifications
    Product Name Retatrutide (LY3437943)
    CAS No. 2381089‑83‑2
    Appearance White to off‑white lyophilized powder

    Product Usage  

    1.Helps slow food leaving your stomach

    2.Helps the pancreas produce more insul when your blood sugar levels are high

    3.Can reduce hyperglycemia, especially after meals

    4.Has been shown to lower triglyceride levels and oxidative stress from high LDL

    5.Helps prevent your liver from making too much sugar

    6.Can help control blood glucose

    7.Can reduce fasting insul and fasting glucose

    8.Can decrease appetite and caloric intake, while inhibiting weight gain

    Shop High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size-Detailed Image 1
    Shop High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size-Detailed Image 2
    Shop High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size-Detailed Image 3
    Shop High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size-Detailed Image 4
    Shop High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size-Detailed Image 5
    Shop High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size-Detailed Image 6







    Why choose us?

    Our Advantages:
    1.High quality with competitive price.
    2.All purity>99%.
    3. We are manufacturer and can provide high quality products with factory price.

    Fast and safe delivery:
    1. Parcel can be sent out in 48 hours after payment tracking number available.
    2. Secure and discreet shipment verious transportation methods for your choice.
    3. Customs pass rate >99%.


    Shop High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size-Detailed Image 7
    Shop High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size-Detailed Image 8
    Shop High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size-Detailed Image 9
    Shop High quality at a low price Retatrutide LY 3437943 Triple GLP 1 GIP GCGR Receptor Agonist Peptide Lyophilized Powder Custom Vial Size-Detailed Image 10
    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Polypeptide

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    PEPTIDES

    Location:

    Room 305, 3rd Floor, Unit 2, Building 48, Datangxia Zone 2, Choucheng Subdistrict, Yiwu, Jinhua, Zhejiang Province, China

    Year of Establishment:

    2026

  • Inquiry History
    6842 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Australia

    GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2

    10 G Jun 12, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.